Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting

Use your browser's Back button to return to your search results

Reporting guideline provided for? (i.e. exactly what the authors state in the paper)	Reporting risk of recurrent venous thromboembolism (VTE) after stopping anticoagulant therapy
Full bibliographic reference	Kearon C, Iorio A, Palareti G; Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost. 2010; 8(10):2313-2315.
Language	English
PubMed ID	20738761
Study design	Observational studies
Clinical area	Cardiovascular medicine, Respiratory medicine
Applies to the whole report or to individual sections of the report?	Outcomes (variables), Study characteristics (participants etc.)
Record last updated on	January 27, 2015

Randomised trials	CONSORT	Extensions
Observational studies	STROBE	Extensions
Systematic reviews	PRISMA	Extensions
Case reports	CARE	Extensions
Qualitative research	SRQR	COREQ
Diagnostic / prognostic studies	STARD	TRIPOD
Quality improvement studies	SQUIRE
Economic evaluations	CHEERS
Animal pre-clinical studies	ARRIVE
Study protocols	SPIRIT	PRISMA-P
Clinical practice guidelines	AGREE	RIGHT